Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4787158
Max Phase: Preclinical
Molecular Formula: C22H32O7
Molecular Weight: 408.49
Molecule Type: Unknown
Associated Items:
ID: ALA4787158
Max Phase: Preclinical
Molecular Formula: C22H32O7
Molecular Weight: 408.49
Molecule Type: Unknown
Associated Items:
Canonical SMILES: COC(=O)/C=C1\CC[C@H]2[C@@H](C(=O)[C@H](O)[C@@H]3[C@]2(C)CC[C@H](O)[C@]3(C)C(=O)OC)[C@H]1C
Standard InChI: InChI=1S/C22H32O7/c1-11-12(10-15(24)28-4)6-7-13-16(11)17(25)18(26)19-21(13,2)9-8-14(23)22(19,3)20(27)29-5/h10-11,13-14,16,18-19,23,26H,6-9H2,1-5H3/b12-10+/t11-,13-,14-,16-,18-,19+,21+,22-/m0/s1
Standard InChI Key: JRAPBYMPTOWDPY-UGQXGAMHSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 408.49 | Molecular Weight (Monoisotopic): 408.2148 | AlogP: 1.65 | #Rotatable Bonds: 2 |
Polar Surface Area: 110.13 | Molecular Species: NEUTRAL | HBA: 7 | HBD: 2 |
#RO5 Violations: 0 | HBA (Lipinski): 7 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: 13.08 | CX Basic pKa: | CX LogP: 1.98 | CX LogD: 1.98 |
Aromatic Rings: 0 | Heavy Atoms: 29 | QED Weighted: 0.53 | Np Likeness Score: 2.61 |
1. Vo PHT,Nguyen TDT,Tran HT,Nguyen YN,Doan MT,Nguyen PH,Lien GTK,To DC,Tran MH. (2021) Cytotoxic components from the leaves of Erythrophleum fordii induce human acute leukemia cell apoptosis through caspase 3 activation and PARP cleavage., 31 [PMID:33161122] [10.1016/j.bmcl.2020.127673] |
Source(1):